HYPOTHALAMIC OBESITY
Clinical trials for HYPOTHALAMIC OBESITY explained in plain language.
Never miss a new study
Get alerted when new HYPOTHALAMIC OBESITY trials appear
Sign up with your email to follow new studies for HYPOTHALAMIC OBESITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New study tests Weight-Loss drug in rare obesity conditions
Disease control Recruiting nowThis study tests the weight-loss drug tirzepatide in young adults aged 18-26 with Prader-Willi syndrome, hypothalamic obesity, or general obesity. Participants take the medication for one year to see how much weight they lose and how other health measures change. The goal is to s…
Matched conditions: HYPOTHALAMIC OBESITY
Phase: PHASE4 • Sponsor: Grace Kim • Aim: Disease control
Last updated May 26, 2026 12:03 UTC
-
Hope for rare obesity: daily shot targets Brain-Related weight gain
Disease control Recruiting nowThis study tests a daily injection called setmelanotide to help people aged 4 and older who have severe weight gain due to a brain condition (hypothalamic obesity). Participants receive either the drug or a placebo for 26 weeks. The goal is to see if the drug reduces body mass in…
Matched conditions: HYPOTHALAMIC OBESITY
Phase: PHASE3 • Sponsor: Rhythm Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 12:03 UTC
-
New weekly shot targets genetic obesity in early trial
Disease control Recruiting nowThis study tests a new weekly injection called RM-718 in 150 people with obesity, including those with a genetic condition affecting the MC4R pathway (like Prader-Willi syndrome). The main goal is to check safety and how the drug moves through the body. It is an early-phase trial…
Matched conditions: HYPOTHALAMIC OBESITY
Phase: PHASE1, PHASE2 • Sponsor: Rhythm Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 19, 2026 11:47 UTC